Barclays Maintains Underweight on Addus HomeCare, Raises Price Target to $101
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $96 to $101.
Barclays analyst Andrew Mok maintains Addus HomeCare (NASDAQ:ADUS) with a Underweight and raises the price target from $96 to $101.